Today, September 13, 2017, Emily Leonard, a US Navy veteran and UC San Diego alumna, spoke on behalf of UACT and Universities Allied for Essential Medicines before the University of California Board of Regents. ┬áMs. Leonard delivered a copy of the letter sent to the Regents on May 24, 2017 asking the University of California to drop its pursuit of a patent on the prostate cancer drug enzalutamide (sold by Astellas as Xtandi) in India. The Board of Regents has yet to reply to the May 24, 2017 letter, or a follow-up letter sent on August 9, 2017 to Regents member Sherry Lansing. You canRead More →